anti-FLT3/CD3 BiTE antibody AMG 427
Term · Oncology and biomedicine · MLC-T-ONC-010665
A bispecific T-cell engager (BiTE) antibody composed of two single-chain variable fragments (scFv), one directed against the tumor-associated antigen (TAA) FLT3 tyrosine kinase receptor (Fms-like tyrosine kinase 3; FLT3; FLT-3; CD135; fetal liver kinase-2; FLK2), fused to one that is directed against the CD3 antigen found on T lymphocytes, with potential immunostimulating and antineoplastic activities. Upon administration of anti-FLT3/CD3 BiTE antibody AMG 427, this bispecific antibody binds to both CD3 on cytotoxic T lymphocytes (CTLs) and FLT3 found on FLT3-expressing tumor cells. This activates and redirects CTLs to FLT3-expressing tumor cells, which results in the CTL-mediated cell death of FLT3-expressing tumor cells. FLT3, a cytokine receptor belonging to the class III tyrosine kinase receptors, is overexpressed or mutated in most B-lineage and acute myeloid leukemias (AMLs).
| Identifier | MLC-T-ONC-010665 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-FLT3 x anti-CD3 BiTE AMG 427; BiTE antibody AMG 427; bispecific T-cell engager antibody AMG 427; FLT3/CD3-directed bispecific T-cell engager antibody AMG 427 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010665",
"term": "anti-FLT3/CD3 BiTE antibody AMG 427",
"field": "Oncology and biomedicine",
"definition": "A bispecific T-cell engager (BiTE) antibody composed of two single-chain variable fragments (scFv), one directed against the tumor-associated antigen (TAA) FLT3 tyrosine kinase receptor (Fms-like tyrosine kinase 3; FLT3; FLT-3; CD135; fetal liver kinase-2; FLK2), fused to one that is directed against the CD3 antigen found on T lymphocytes, with potential immunostimulating and antineoplastic activities. Upon administration of anti-FLT3/CD3 BiTE antibody AMG 427, this bispecific antibody binds to both CD3 on cytotoxic T lymphocytes (CTLs) and FLT3 found on FLT3-expressing tumor cells. This activates and redirects CTLs to FLT3-expressing tumor cells, which results in the CTL-mediated cell death of FLT3-expressing tumor cells. FLT3, a cytokine receptor belonging to the class III tyrosine kinase receptors, is overexpressed or mutated in most B-lineage and acute myeloid leukemias (AMLs).",
"synonyms": [
"anti-FLT3 x anti-CD3 BiTE AMG 427",
"BiTE antibody AMG 427",
"bispecific T-cell engager antibody AMG 427",
"FLT3/CD3-directed bispecific T-cell engager antibody AMG 427"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-flt3-cd3-bite-antibody-amg-427/"
}
Record 1,766 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.